LIFETECH SCI.DL-00000125
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more
Market Cap & Net Worth: LIFETECH SCI.DL-00000125 (81X)
LIFETECH SCI.DL-00000125 (F:81X) has a market capitalization of $795.04 Million (€774.54 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #9061 globally and #976 in its home market, demonstrating a 2.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LIFETECH SCI.DL-00000125's stock price €0.18 by its total outstanding shares 4400767400 (4.40 Billion).
LIFETECH SCI.DL-00000125 Market Cap History: 2021 to 2026
LIFETECH SCI.DL-00000125's market capitalization history from 2021 to 2026. Data shows change from $1.73 Billion to $795.04 Million (-16.89% CAGR).
LIFETECH SCI.DL-00000125 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LIFETECH SCI.DL-00000125's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 81X by Market Capitalization
Companies near LIFETECH SCI.DL-00000125 in the global market cap rankings as of March 19, 2026.
Key companies related to LIFETECH SCI.DL-00000125 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
LIFETECH SCI.DL-00000125 Historical Marketcap From 2021 to 2026
Between 2021 and today, LIFETECH SCI.DL-00000125's market cap moved from $1.73 Billion to $ 795.04 Million, with a yearly change of -16.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €795.04 Million | +12.10% |
| 2025 | €709.21 Million | -2.48% |
| 2024 | €727.28 Million | -34.55% |
| 2023 | €1.11 Billion | -8.21% |
| 2022 | €1.21 Billion | -29.84% |
| 2021 | €1.73 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of LIFETECH SCI.DL-00000125 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $795.04 Million USD |
| MoneyControl | $795.04 Million USD |
| MarketWatch | $795.04 Million USD |
| marketcap.company | $795.04 Million USD |
| Reuters | $795.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.